Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-25-060882
Filing Date
2025-04-30
Accepted
2025-04-30 13:52:16
Documents
15
Period of Report
2025-06-12

Document Format Files

Seq Description Document Type Size
1 DEF 14A hrtx-20250430.htm   iXBRL DEF 14A 1649854
2 GRAPHIC img166033857_0.jpg GRAPHIC 459335
3 GRAPHIC img166033857_1.jpg GRAPHIC 330896
  Complete submission text file 0000950170-25-060882.txt   4847132

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT hrtx-20250430.xsd EX-101.SCH 12943
17 EXTRACTED XBRL INSTANCE DOCUMENT hrtx-20250430_htm.xml XML 560825
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33221 | Film No.: 25893570
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)